A targetable pathway to eliminate TRA-1-60(+) /TRA-1-81(+) chemoresistant cancer cells Journal Article


Authors: Tan, L.; Duan, X.; Mutyala, P.; Zhou, T.; Amin, S.; Zhang, T.; Herbst, B.; Askan, G.; Itkin, T.; Xiang, Z.; Michelassi, F.; Lieberman, M. D.; Iacobuzio-Donahue, C. A.; Leach, S. D.; Evans, T.; Chen, S.
Editor: Lu, H.
Article Title: A targetable pathway to eliminate TRA-1-60(+) /TRA-1-81(+) chemoresistant cancer cells
Abstract: Chemoresistance is a primary cause of treatment failure in pancreatic cancer. Identifying cell surface markers specifically expressed in chemoresistant cancer cells( CCCs) could facilitate targeted therapies to overcome chemoresistance. We performed an antibody- based screen and found that TRA-1-60 and TRA-1-81, two 'stemness' cell surface markers, are highly enriched in CCCs. Further- more, TRA-1-60+ /TRA-1-81+ cells are chemoresistant compared to TRA-1-60-/TRA-1-81-cells. Transcriptome profiling identified UGT1A10 , shown to be both necessary and sufficient to maintain TRA-1-60/TRA-1-81 expression and chemoresistance. From a high- content chemical screen, we identified Cymarin, which downregulates UGT1A10 , eliminates TRA-1-60/TRA-1-81 expression, and increases chemosensitivity both in vitro and in vivo . Finally, TRA-1-60/TRA-1-81 expression is highly specific in primary cancer tissue and positively correlated with chemoresistance and short survival, which highlights their potentiality for targeted therapy. Therefore, we discovered a novel CCC surface marker regulated by a pathway that promotes chemoresistance, as well as a leading drug candidate to target this pathway. © The Author(s) (2023).
Keywords: pancreatic neoplasms; gene expression profiling; drug resistance; drug resistance, neoplasm; cell line, tumor; pancreas tumor; tumor cell line; pancreatic cancer; chemoresistance; cymarin; humans; human; tra-1-60/tra-1-81; ugt1a10
Journal Title: Journal of Molecular Cell Biology
Volume: 15
Issue: 6
ISSN: 1674-2788
Publisher: Oxford University Press  
Date Published: 2023-06-01
Start Page: mjad039
Language: English
DOI: 10.1093/jmcb/mjad039
PUBMED: 37327088
PROVIDER: scopus
PMCID: PMC10847630
DOI/URL:
Notes: Article -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gokce Askan
    77 Askan
  2. Brian Thomas Herbst
    5 Herbst
  3. Ting Zhou
    26 Zhou